What the ProDentim ingredient panel discloses
ProDentim’s published panel identifies ingredient amounts but leaves important strain-level questions unanswered. This audit separates the three-organism blend from the separately listed Streptococcus salivarius and the inactive ingredients. For the overall product decision, see the ProDentim review; this page focuses on what the panel can support and what needs clarification.
| Panel entry | Amount per tablet | Identity detail | Disclosure boundary | Buyer implication |
|---|---|---|---|---|
| Chicory-root inulin | 100 mg | Cichorium intybus | Preparation detail beyond the botanical source is limited. | Do not equate this amount with gram-scale inulin trial regimens. |
| Probiotic blend | 20 mg; 3.5 billion combined CFU at manufacture | L. paracasei, L. reuteri, B. lactis BL-04 | Individual quantities/counts unspecified; first two lack strain codes. | The total cannot establish a matching research dose for each organism. |
| S. salivarius | 20 mg | Species, without strain code | No individual CFU stated on this panel. | Do not assume this is K12, M18 or part of the 3.5-billion count. |
| Other ingredients | No individual quantities shown | Tricalcium phosphate, MCC, natural strawberry flavor, peppermint essential oil | Flavor composition and allergen cross-contact are not resolved by these names. | A relevant allergy needs direct confirmation, not an assumption based on fruit imagery. |
| Sales narrative differences | No reconciled panel amount | Malic acid appears in the sales text | It is absent from this inspected panel. | Ask which current label/version applies to the item being sold. |
Blend math: useful bounds, not discovered doses
The 20 mg blend contains three named organisms, but its arithmetic cannot reveal their actual allocation. Equal division would produce an average of about 6.67 mg and 1.17 billion CFU per organism. These are hypothetical means, not labeled amounts, and they cannot establish whether any clinical preparation or dose is matched.
| Calculation | Mathematical result | What it does not mean |
|---|---|---|
| 20 mg ÷ 3 organisms | 6.67 mg average if equally allocated. | No evidence that the blend is equally divided or that mass predicts viability. |
| 3.5 billion CFU ÷ 3 | About 1.17 billion CFU each under an equal-count assumption. | Not the actual BL-04, L. reuteri or L. paracasei count. |
| Maximum ceiling per blend member | No member can exceed the stated combined 20 mg or 3.5 billion CFU total. | A ceiling is not a measured amount or proof of clinical underdosing. |
| Separate S. salivarius entry | 20 mg outside the three-organism blend listing. | Its live-cell count cannot be inferred from mass or added to the blend CFU without data. |
NIH distinguishes live colony-forming units from a supplement’s weight and notes that effects depend on the strain and indication. A manufacturing-time count also differs from a guarantee through expiration. Ask for the strain designations, per-strain viable counts and storage/expiry specifications rather than assuming a larger printed total is better. NIH Office of Dietary Supplements [1]
How the ingredients compare with human research
The most important mismatch is identity, not a calculation proving that ProDentim is underdosed. HN019, BL-04, SD1 and K12 are distinct strain designations, while several panel entries stop at species level. Human findings must also match the preparation, population and outcome; an oral bacterial count is not the same endpoint as repaired teeth.
| Entry | Human evidence inspected | Preparation / exposure | Applicability verdict |
|---|---|---|---|
| B. lactis BL-04 | Invernici et al. studied HN019 in 41 adults receiving periodontal treatment. Invernici et al. (2018) [2] | One billion CFU per lozenge, twice daily for 30 days; 90-day follow-up. | Different strain and treatment context. Neither a species name nor combined CFU establishes equivalence. |
| L. paracasei | Teanpaisan and Piwat studied SD1 in 40 young adults. Teanpaisan and Piwat (2014) [3] | Milk powder once daily for four weeks; matching CFU dose not specified in the inspected abstract. | Salivary mutans-streptococci changes do not establish clinical cavity prevention by this unspecified-strain tablet. |
| L. reuteri | The periodontal meta-analysis includes varied probiotic regimens and mixed findings. Benavides-Reyes et al. (2025) [4] | Strain, form and duration differ across studies. | No single universal species dose can be assigned to the panel’s unspecified strain. |
| S. salivarius | He et al. studied K12 in 28 people with tongue-coating halitosis. He et al. (2020) [5] | Thirty-day tablet intervention; no significant between-group improvement. | K12 is not identified on the panel, and a milligram quantity cannot establish the trial’s viable dose. |
| Inulin | Bonnema et al. evaluated gastrointestinal tolerance in 26 healthy adults. Bonnema et al. (2010) [6] | Five- or ten-gram inulin/oligofructose preparations; short-term symptom assessment. | Different preparation, dose and outcome. This is not evidence that 100 mg improves oral health. |
The panel supplies a starting point for comparison, not a demonstration of synergy. See the effectiveness assessment for advertised benefits, finished-formula searches and the implications of favorable, negative and inconclusive findings. General ingredient education belongs in the ingredient library rather than being treated as proof of this product.
Other ingredients, flavor and allergy questions
The inspected panel names four other ingredients, but those names do not establish a complete allergen or cross-contact guarantee. Natural strawberry flavor is not the same as a quantified strawberry ingredient, and peppermint imagery is not a dose declaration. Anyone with a relevant sensitivity should obtain current manufacturer information before using the tablet.
- Tricalcium phosphate and microcrystalline cellulose are listed without individual quantities. Their presence should not be converted into an unsupported nutritional or therapeutic claim.
- Natural strawberry flavor and peppermint essential oil may matter to a person with a known sensitivity, but the panel does not settle every flavor constituent or cross-contact question.
- Malic acid appears in sales copy rather than this panel. Its status is a document discrepancy, not proof of adulteration or a confirmed formula change.
This artwork includes general allergy and medical-consultation cautions. It is not a laboratory analysis or an independently authenticated label for a received lot. If your bottle differs, photograph its full panel and contact the seller before use. The safety assessment addresses reactions and higher-risk situations without inferring safety from missing amounts.
Questions worth taking to your dentist or clinician
A useful consultation connects the actual bottle to your diagnosis and medical circumstances. Ask whether an optional probiotic has a plausible role after your existing treatment needs are addressed. Bring the panel and directions, because online conflicts about organism identity and tablet use cannot be resolved by the product name alone.
- Which oral problem is being assessed: plaque, gum inflammation, periodontitis, dry mouth or persistent malodour? Does it need treatment rather than a supplement?
- Is the strain and preparation proposed relevant to that problem, and is any expected benefit meaningful beside current care?
- Do immune status, prescribed medicines, pregnancy, breastfeeding or allergies make this product unsuitable or require further advice?
- Can the seller provide a current bottle label, strain IDs, expiry-potency information and consistent directions?
- How will progress be assessed without delaying a dental review or changing prescribed care?
For wider distinctions among symptoms, diseases and prevention, see our oral health guide. This ingredient audit does not diagnose a condition or prescribe a dose.
ProDentim ingredient questions
Ingredient names alone do not answer whether a particular ProDentim bottle matches a studied preparation. These questions focus on blend interpretation, strain codes and the discrepancy between sales copy and the panel. Preserve those distinctions when comparing products; a confident numerical claim is useful only when its source and meaning are clear.
Does 3.5 billion CFU mean that much of every organism?
Is BL-04 the same as HN019?
Does ProDentim contain malic acid?
Can 20 mg tell me the number of live bacteria?
Does the panel prove independent quality certification?
Complete ProDentim assessment series
The overall product, evidence and purchase assessment.
Amounts, strains, excipients and label discrepancies.
Benefit claims, human trials and realistic expectations.
Tolerability, medication questions and higher-risk use.
Attributed feedback, return friction and alternatives.
Sources and references
- NIH Office of Dietary Supplements. Probiotics: Health Professional Fact Sheet. Strain specificity, potency labeling and safety.
- Invernici et al. (2018). Bifidobacterium animalis subsp. lactis HN019 as an adjunct to periodontal treatment. J Clin Periodontol. 45:1198–1210. DOI:10.1111/jcpe.12995. Full-paper methods/results inspected via PMC6221043.
- Teanpaisan and Piwat (2014). Lactobacillus paracasei SD1 reduces mutans streptococci in human volunteers. Clin Oral Investig. 18:857–862. Abstract inspected.
- Benavides-Reyes et al. (2025). Probiotics as adjunctive therapy for gingivitis and periodontitis: systematic review and meta-analysis. Abstract inspected; protocols and effects varied.
- He et al. (2020). Streptococcus salivarius K12 for oral malodour: randomized placebo-controlled clinical trial. Abstract inspected.
- Bonnema et al. (2010). Gastrointestinal tolerance of chicory inulin products. Abstract inspected; healthy adults, gram-scale preparations.
Affiliate disclaimer: Marked purchase links may pay FitnessLifeMag a commission. This relationship does not turn independent research citations into paid links. Read our affiliate disclosure.
Educational information: This assessment is not diagnosis, treatment or personalized medical advice. Consult a qualified dental or medical professional about symptoms, suitability and treatment decisions.